US-based drugs company Aralez Pharmaceuticals has filed a patent infringement complaint against Teva centring on the drug Yosprala (aspirin and omeprazole), a delayed-release aspirin.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Aralez, Teva, ANDA, FDA, Yosprala, aspirin, patent, patent infringement, generics